default author photo

Akihide Ryo

Yokohama City University - Department of Microbiology

Japan

  • Yokohama City University - Department of Microbiology

SCHOLARLY PAPERS

3

DOWNLOADS

152

TOTAL CITATIONS

2

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

SARS-CoV-2 Prevalence in Saliva and Gastric and Intestinal Fluid in Patients Undergoing Gastrointestinal Endoscopy in COVID-19 Endemic Areas: Prospective Cross-Sectional Study in Japan

Number of pages: 29 Posted: 28 Oct 2020
Shigeta Miyake, Keiichi Ashikari, Shingo Kato, Tomohiro Takatsu, Hirofumi Kuwashima, Hiroaki Kaneko, Koki Nagai, Ikue Watari, Takamitsu Sato, Yutaro Yamaoka, Tetsuya Yamamoto, Akihide Ryo, Shin Maeda, Atsushi Nakajima and Takuma Higurash
Yokohama City University - Department of Neurology, Yokohama City University - Department of Gastroenterology and Hepatology, Yokohama City University - Department of Gastroenterology and Hepatology, Yokohama City University - Department of Gastroenterology and Hepatology, Yokohama City University - Department of Gastroenterology, Yokohama City University - Department of Gastroenterology, Yokohama City University - Department of Gastroenterology and Hepatology, Yokohama City University - Department of Gastroenterology and Hepatology, Yokohama City University - Department of Gastroenterology and Hepatology, Yokohama City University - Department of Microbiology, Yokohama City University - Department of Neurology, Yokohama City University - Department of Microbiology, Yokohama City University - Department of Gastroenterology, Yokohama City University - Department of Gastroenterology and Hepatology and Yokohama City University - Department of Gastroenterology and Hepatology
Downloads 60 (961,006)
Citation 1

Abstract:

Loading...

COVID-19, SARS-CoV-2, saliva, gastric fluid, intestinal fluid, Endoscopy, healthy subject

2.

Identification of Serum Prognostic Biomarkers of Severe COVID-19 by Multi-Layered Quantitative Proteomic Approach

Number of pages: 67 Posted: 06 Nov 2020
Yayoi Kimura, Yusuke Nakai, Jihey Shin, Miyui Hara, Yuriko Takeda, Sousuke Kubo, Sundararaj Stanleyraj Jeremiah, Yoko Ino, Tomoko Akiyama, Kayano Moriyama, Kazuya Sakai, Ryo Saji, Mototsugu Nishii, Hideya Kitamura, Kota Murohashi, Kouji Yamamoto, Takeshi Kaneko, Ichiro Takeuchi, Eri Hagiwara, Takashi Ogura, Tomohiko Tamura, Takeharu Yamanaka and Akihide Ryo
Yokohama City University - Advanced Medical Research Center, Yokohama City University - Advanced Medical Research Center, Yokohama City University - Advanced Medical Research Center, Yokohama City University - School of Medicine Medical Course Biostatistics, Yokohama City University - School of Medicine Medical Course Biostatistics, Yokohama City University - Department of Microbiology, Yokohama City University - Department of Microbiology, Yokohama City University - Advanced Medical Research Center, Yokohama City University - Advanced Medical Research Center, Yokohama City University - Advanced Medical Research Center, Yokohama City University - School of Medicine Medical Course Emergency Medicine, Yokohama City University - School of Medicine Medical Course Emergency Medicine, Yokohama City University - School of Medicine Medical Course Emergency Medicine, Kanagawa Cardiovascular and Respiratory Center - Department of Respiratory Medicine, Yokohama City University - Department of Pulmonology, Yokohama City University - School of Medicine Medical Course Biostatistics, Yokohama City University - Department of Pulmonology, Yokohama City University - School of Medicine Medical Course Emergency Medicine, Kanagawa Cardiovascular and Respiratory Center - Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center - Department of Respiratory Medicine, Yokohama City University - Department of Immunology, Yokohama City University - School of Medicine Medical Course Biostatistics and Yokohama City University - Department of Microbiology
Downloads 50 (1,063,489)
Citation 1

Abstract:

Loading...

COVID-19, Proteomics, Biomarker, Prognosis, Diagnosis

3.

Highly Specific Monoclonal Antibodies Against SARS-CoV-2 Nucleocapsid Antigen for Accurate Diagnosis of COVID-19

Number of pages: 33 Posted: 29 Oct 2020
Yutaro Yamaoka, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Koji Okudela, Mayuko Nishi, Sayaka Kikuchi, Shuzo Usuku, Chiharu Kawakami, Nobuko Tanaka, Takeshi Morita, Hiroyuki Hayashi, Hideaki Mitsui, Keita Suzuki, Daisuke Aizawa, Yukihiro Yoshimura, Tomoyuki Miyazaki, Etsuko Yamazaki, Tadaki Suzuki, Hirokazu Kimura, Hideki Hasegawa and Akihide Ryo
Yokohama City University - Department of Microbiology, Yokohama City University - Department of Microbiology, Yokohama City University - Department of Microbiology, Yokohama City University - Department of Pathology, Yokohama City University - Department of Microbiology, Kanto Chemical Co., Inc. - Life Science Laboratory, Yokohama City Institute of Public Health, Yokohama City Institute of Public Health, Yokohama City Institute of Public Health, Yokohama City University - Department of Microbiology, Yokohama Municipal Citizen's Hospital - Division of Pathology, Yokohama City University - Department of Pathology, Kanto Chemical Co., Inc. - Life Science Laboratory, Kanto Chemical Co., Inc. - Life Science Laboratory, Yokohama Municipal Citizen's Hospital - Division of Infectious Disease, Yokohama City University - Department of Physiology, Yokohama City University - Clinical Laboratory Department, National Institute of Infectious Diseases - Department of Pathology, Gunma Paz University - School of Medical Technology, Faculty of Health Sciences, National Institute of Infectious Diseases - Department of Pathology and Yokohama City University - Department of Microbiology
Downloads 42 (1,157,785)

Abstract:

Loading...

COVID-19, SARS-CoV-2, monoclonal antibody, nucleoprotein, point-of-care testing